Panel Reports on State of Drug Safety
A panel convened by The Institute of Medicine has released a report called "The Future of Drug Safety." The report addresses drug safety in the U.S. and issues within the FDA.
The panel found that the FDA is lacking the funding and manpower to do its job properly. They also found that new drugs are given too much leeway before their safety has been properly established and that drugs should continue to be reviewed for safety five years after they are put on the market.
"More drugs are being approved faster with less time to intensively investigate premarketing safety data," the report said. And FDA does not have the resources to keep up once the drugs reach the market in assessing safety or informing the public about any risks that might develop.
Filed under FDA